| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |